Pharmact at a Glance
Pharmact is a medtech company focusing on preventing disease through early detection. The company’s international team of medical experts provides healthcare professionals with qualitative point-of-care rapid tests for the early detection of chronic diseases such as type 2 diabetes mellitus and liver fibrosis, as well as acute myocardial infarction.
To help tackle the COVID-19 global pandemic, Pharmact has developed a highly sensitive and accurate antibody test. The BELTEST-IT COV-2 Rapid Test is an immunochromatographic test for the qualitative detection of immunoglobins M (IgM) and G (IgG) against the SARS-CoV-2 virus in human whole blood and serum. The test assists in determining possible immune reaction against coronavirus infection.
Pharmact’ s most recent project currently under development, is a revolutionary drug that combats arteriosclerosis. An international board of trustees supports its development.
Founded in Berlin, Pharmact’ s international distribution headquarters is located at CUBEX 41, the innovative center for medtech start-ups based on the University Hospital Mannheim campus. The company is operated in the United States by Pharmact Healthcare Inc. in Chapel Hill, North Carolina.
A world free from chronic disease.
We are committed to improving the health of the global community through the early diagnosis of chronic disease.
Commitment. Passion. Integrity. Empathy. Respect.